GLOBAL X S&P BIOTECH ETF - AUD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.68 AUD | +2.25% |
|
-2.02% | -4.59% |
Investment objective
The Global X S&P Biotech ETF (CURE) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 64.38 USD | -1.48% | -3.09% | -23.06% | 2.53% | ||
| 11.98 USD | +2.96% | +5.06% | +46.28% | 2.43% | ||
| 75.77 USD | +1.96% | +18.83% | +307.71% | 1.91% | ||
| 129.9 USD | +0.86% | +10.20% | +33.66% | 1.74% | ||
| 8.475 USD | +4.37% | +10.46% | -14.86% | 1.67% | ||
| 39.17 USD | +0.51% | -0.05% | -8.95% | 1.58% | ||
| 61.68 USD | +1.57% | -0.57% | -2.47% | 1.50% | ||
| 6.455 USD | +0.55% | -2.07% | +2.82% | 1.47% | ||
| 55.24 USD | +2.46% | -2.12% | -12.97% | 1.44% | ||
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/24/29 | 43.68 | +2.25% | 744 |
| 26/24/26 | 42.72 | -3.57% | 6,112 |
| 24/24/24 | 44.3 | -0.45% | 1,213 |
| 23/24/23 | 44.5 | -0.18% | 5,284 |
| 22/24/22 | 44.58 | +1.92% | 602 |
Other stock markets
Delayed Quote Australian S.E.
Last update April 29, 2024 at 11:40 am IST
More quotesDescription
| AU0000028110 | |
|---|---|
| Total Expense Ratio | 0.45% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | S&P Biotechnology Select Industry Net Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Fund Structure | |
| Replication Method | |
| Replication Model | |
| Date of creation |
08/11/2018
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 27/03/2024 )
| AuM (EUR) | 25 M€ |
|---|---|
| AuM 1M | 27 M€ |
| AuM 3 months | 25 M€ |
| AuM 6 months | 20 M€ |
| AuM 12 months | 24 M€ |
- Stock Market
- ETF
- CURE ETF
